Agent setup
Give Claude a pipeline database
Connect once and ask about any drug, trial or company in plain English. Claude gets five tools and answers with source links.
1
Get your connector URL
Sign in (free), then create a key. The URL includes your key: keep it private.
https://openlandscape.app/mcp/u/YOUR_KEYSign in2
Add it in Claude
Settings → Connectors → Add custom connector. Paste the URL, name it OpenLandscape, click Add.
3
Ask something
Start a chat and try:
Map every amylin drug in Phase 2 or later, with next catalyst.1
Run one command
In your terminal, with your key:
claude mcp add --transport http openlandscape https://openlandscape.app/mcp/u/YOUR_KEY2
Add the skill (optional)
Teaches Claude to write a landscape memo with sources. Save it as ~/.claude/skills/openlandscape/SKILL.md.
mkdir -p ~/.claude/skills/openlandscape && curl -so ~/.claude/skills/openlandscape/SKILL.md https://openlandscape.app/skill/SKILL.md1
Run it on your own machine
Same server, your hardware. Free under AGPL. Needs Node 22; the first data load takes about two minutes.
Repository opens Nov 2026
The five tools
searchFind a drug, disease or company under any of its names.landscapeEvery program in an area, as a compact table.trialsTrials by disease, phase, sponsor, country, status and dates.catalystsUpcoming readouts and decisions, with sources.who_runs_trialsSponsors and sites ranked by activity in an area.Free plan: 50 calls a day. Solo ($29/mo) removes the limit.
claude · openlandscape · live data
› which oral GLP-1 pills are in phase 3 or later, and who reads out first?
● openlandscape.landscape(area: "oral GLP-1", phase_min: 3)
| drug | company | phase | next |
| orforglipron | Eli Lilly | Approved (US) | Feb 2027 |
| HRS-7535 | Hengrui | Filed (China) | Dec 2026 |
| HDM1002 | Huadong Medicine | Phase 3 | 16 Feb 2027 |
| MDR-001 | MindRank AI | Phase 3 | Jun 2027 |
| VK2735 | Viking | Phase 3 | 1 Jul 2027 |
| DA-302168S | Chengdu DIAO | Phase 3 | 9 Jul 2027 |
| elecoglipron | AstraZeneca | Phase 3 | 6 Apr 2028 |
| ASC30 | Ascletis | Phase 3 | Jul 2028 |
9 drug programs in Phase 3 or later, across 56 active trials. The first registry date is HRS-7535 (Hengrui · Kailera), Dec 2026, NCT06820099.
✓ 9 programs · 56 trials · sources attached